INTERNATIONAL PATENT: JOSLIN DIABETES CENTER FILES APPLICATION FOR "USE OF CARDIAC AUTOANTIBODIES AS A METHOD TO IDENTIFY INDIVIDUALS AT INCREASED RISK OF DEVELOPING CARDIOVASCULAR EVENTS"

GENEVA, Aug. 26 -- JOSLIN DIABETES CENTER (One Joslin PlaceBoston, Massachusetts 02215) filed a patent application (PCT/US2025/015439) for "USE OF CARDIAC AUTOANTIBODIES AS A METHOD TO IDENTIFY INDIVIDUALS AT INCREASED RISK OF DEVELOPING CARDIOVASCULAR EVENTS" on Feb 11, 2025. With publication no. WO/2025/174781, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIPES, Myra A. (c/o Joslin Diabetes CenterOne Joslin PlaceBoston, Massachusetts 02215), SOUSA, Giovane R. (c/o Joslin Diabetes CenterOne Joslin PlaceBoston, Massach...